News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
748,547 Results
Type
Article (67700)
Company Profile (436)
Press Release (680410)
Multimedia
Podcasts (136)
Webinars (19)
Section
Business (199418)
Career Advice (3810)
Deals (35771)
Drug Delivery (129)
Drug Development (85523)
Employer Resources (199)
FDA (17136)
Job Trends (15795)
News (348395)
Policy (35243)
Tag
Academia (2969)
Academic (1)
Accelerated approval (14)
Adcomms (33)
Allergies (109)
Alliances (50731)
ALS (122)
Alzheimer's disease (1610)
Antibody-drug conjugate (ADC) (190)
Approvals (17092)
Artificial intelligence (367)
Autoimmune disease (38)
Automation (19)
Bankruptcy (359)
Best Places to Work (12348)
BIOSECURE Act (22)
Biosimilars (137)
Biotechnology (323)
Bladder cancer (102)
Brain cancer (40)
Breast cancer (406)
Cancer (3174)
Cardiovascular disease (257)
Career advice (3250)
Career pathing (34)
CAR-T (214)
CDC (43)
Cell therapy (581)
Cervical cancer (24)
Clinical research (70100)
Collaboration (1149)
Company closure (3)
Compensation (694)
Complete response letters (39)
COVID-19 (2896)
CRISPR (70)
C-suite (388)
Cystic fibrosis (124)
Data (3245)
Decentralized trials (2)
Denatured (47)
Depression (82)
Diabetes (379)
Diagnostics (6793)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (167)
Drug pricing (155)
Drug shortages (36)
Duchenne muscular dystrophy (160)
Earnings (78888)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (119860)
Executive appointments (909)
FDA (18992)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1021)
Gene editing (151)
Generative AI (32)
Gene therapy (458)
GLP-1 (936)
Government (5166)
Grass and pollen (7)
Guidances (221)
Healthcare (20555)
HIV (44)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (191)
Immuno-oncology (13)
Indications (42)
Infectious disease (3099)
Inflammatory bowel disease (167)
Inflation Reduction Act (13)
Influenza (75)
Intellectual property (129)
Interviews (743)
IPO (16924)
IRA (57)
Job creations (3877)
Job search strategy (2644)
Kidney cancer (14)
Labor market (60)
Layoffs (578)
Leadership (27)
Legal (8385)
Liver cancer (85)
Longevity (12)
Lung cancer (448)
Lymphoma (223)
Machine learning (12)
Management (65)
Manufacturing (465)
MASH (103)
Medical device (14216)
Medtech (14222)
Mergers & acquisitions (19627)
Metabolic disorders (969)
Multiple sclerosis (106)
NASH (23)
Neurodegenerative disease (164)
Neuropsychiatric disorders (46)
Neuroscience (2397)
NextGen: Class of 2025 (7416)
Non-profit (5023)
Now hiring (42)
Obesity (497)
Opinion (292)
Ovarian cancer (107)
Pain (128)
Pancreatic cancer (131)
Parkinson's disease (202)
Partnered (22)
Patents (338)
Patient recruitment (185)
Peanut (55)
People (59268)
Pharmaceutical (87)
Pharmacy benefit managers (25)
Phase I (21850)
Phase II (30700)
Phase III (23134)
Pipeline (1782)
Policy (250)
Postmarket research (2811)
Preclinical (9441)
Press Release (71)
Prostate cancer (155)
Psychedelics (46)
Radiopharmaceuticals (278)
Rare diseases (543)
Real estate (6199)
Recruiting (76)
Regulatory (24579)
Reports (62)
Research institute (2629)
Resumes & cover letters (592)
Rett syndrome (10)
RNA editing (12)
RSV (61)
Schizophrenia (104)
Series A (172)
Series B (120)
Service/supplier (12)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (164)
Sponsored (37)
Startups (3765)
State (2)
Stomach cancer (17)
Supply chain (85)
Tariffs (70)
The Weekly (87)
Vaccines (929)
Venture capital (60)
Weight loss (332)
Women's health (50)
Worklife (20)
Date
Last 7 days (538)
Last 30 days (1787)
Last 365 days (32453)
2025 (18982)
2024 (37081)
2023 (41835)
2022 (53134)
2021 (57918)
2020 (56713)
2019 (50353)
2018 (38270)
2017 (35340)
2016 (35246)
2015 (40533)
2014 (33129)
2013 (30702)
2012 (30189)
2011 (30562)
2010 (28363)
Location
Africa (1091)
Alabama (70)
Alaska (7)
Arizona (210)
Arkansas (14)
Asia (44555)
Australia (7801)
California (7824)
Canada (2468)
China (738)
Colorado (329)
Connecticut (354)
Delaware (204)
Europe (102549)
Florida (1183)
Georgia (269)
Hawaii (2)
Idaho (64)
Illinois (720)
India (30)
Indiana (367)
Iowa (19)
Japan (245)
Kansas (113)
Kentucky (32)
Louisiana (17)
Maine (73)
Maryland (1096)
Massachusetts (5993)
Michigan (278)
Minnesota (475)
Mississippi (4)
Missouri (98)
Montana (32)
Nebraska (25)
Nevada (86)
New Hampshire (73)
New Jersey (2205)
New Mexico (31)
New York (2191)
North Carolina (1209)
North Dakota (9)
Northern California (3420)
Ohio (256)
Oklahoma (17)
Oregon (39)
Pennsylvania (1686)
Puerto Rico (18)
Rhode Island (38)
South America (1430)
South Carolina (35)
South Dakota (1)
Southern California (2943)
Tennessee (125)
Texas (1201)
United States (29398)
Utah (229)
Virginia (207)
Washington D.C. (76)
Washington State (688)
West Virginia (4)
Wisconsin (80)
748,547 Results for "be the match biotherapies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies
Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and Cryoport, a leading global provider of innovative products and services to the fast-growing cell & gene therapy industry enabling the future of medicine for a new era of life sciences, announced a new strategic partnership.
October 9, 2023
·
4 min read
Press Releases
Spinal Resources Inc. Announces Publication in Spine Deformity of Impact of a Novel Patient-Specific, Patient-Matched Bezier Parametric Curve Rod Platform on Proximal Junction Biomechanics in an in Silico Thoracolumbar Fusion Model
August 1, 2025
·
3 min read
BioMidwest
NMDP BioTherapies Introduces Enhanced Cellular Materials for Allogeneic Cell Therapy Development
NMDP BioTherapies ℠, formerly Be The Match BioTherapies unveiled substantial upgrades to its cellular starting material offerings, including incorporating a Drug Master File (DMF) with its rapid-delivery, standard GMP leukopak to simplify regulatory filings.
April 16, 2024
·
4 min read
BioMidwest
NMDP BioTherapies To Present Data at ISCT 2024 on the Stability of Infectious Disease Marker Analytes During Donor Qualification for Allogeneic Cell Therapies
NMDP BioTherapies℠ (formerly known as Be The Match BioTherapies) will present a poster at this year’s International Society for Cell & Gene Therapy annual meeting in Vancouver, Canada (ISCT 2024 ) sharing results of a study of the impacts of delayed whole blood processing on the stability of infectious disease marker analytes during donor qualification for allogeneic cell therapies.
May 28, 2024
·
3 min read
BioMidwest
Be The Match BioTherapies® Marks Cord Blood Awareness Month with the Announcement of the Cord Blood Bank Alliance
In anticipation of Cord Blood Awareness Month this July, Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, announced the formation of the Be The Match BioTherapies Cord Blood Bank Alliance.
July 10, 2023
·
3 min read
Government
‘People Are Going to Die’: HHS Hearing With Kennedy Turns Into Shouting Match
With much to cover, Democrats tackled Kennedy’s MAHA report; the firing of all members of the CDC’s ACIP committee; and much more. Little was accomplished, as Kennedy demurred and members of Congress accused him of risking American lives.
June 24, 2025
·
4 min read
·
Annalee Armstrong
Business
NMDP BioTherapies Appoints New President to Lead Next Phase in Life-Saving Therapy Development
NMDP BioTherapies℠, formerly Be The Match BioTherapies, announced that Tom Hochuli will serve as president, leading the organization into its promising future phase.
January 30, 2024
·
4 min read
Press Releases
Rosalind Franklin University Helix 51 Company UP Oncolytics Secures Wisconsin Economic Development Matching Grant to Advance Oncolytic Virus Therapy for Brain Cancer
June 26, 2025
·
1 min read
BioMidwest
The National Marrow Donor Program® (NMDP)/Be The Match® and Be The Match BioTherapies® Mark Clinical Trials Day With New Resources and Services for Patients, Researchers, and Industry Sponsors
The National Marrow Donor Program® /Be The Match® and Be The Match BioTherapies® launched a new web resource page and free white paper, “Paving the way to successful cell therapy clinical trials with a comprehensive approach and patient support,” to mark Clinical Trials Day 2023.
May 17, 2023
·
6 min read
Business
BlueSphere Bio To Partner with NMDP BioTherapies℠ for the Company’s First-In-Human TCR-based Product Candidate in Combination with Allogeneic Hematopoietic Cell Transplantation Trial
BlueSphere Bio, a drug development company focused on novel T-cell receptor (TCR) based therapies for oncology and non-oncology indications, today announced a collaboration with NMDP BioTherapies℠ (formerly Be The Match BioTherapies), an organization offering solutions for companies developing and commercializing cell and gene therapies, to advance BlueSphere’s first clinical trial evaluating a novel cell therapy for patients with high-risk leukemias.
June 25, 2024
·
7 min read
1 of 74,855
Next
